Charles River Laboratories International CRL
NYSE CRL
$342.79 -3.01 (-0.87%)
As of: Nov 11, 2026 · 3:59 PM EST

Charles River Laboratories International (CRL) Return on Equity [ROE] (2009 - 2026)

Updated

Charles River Laboratories International (CRL) recorded Return on Equity [ROE] of -8.16% in Q2 2026, down 6.18 percentage points from -1.98% a year earlier and down 2.18 percentage points from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For FY2025, Charles River Laboratories International reported Return on Equity [ROE] of -4.28%, down 5.00 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for three straight years, with a five-year change of -23.74 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at 0.72% in FY2024 (-13.88 pp), 14.59% in FY2023 (-3.25 pp), 17.85% in FY2022 (+0.72 pp) and 17.13% in FY2021 (-2.32 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] since Q3 2011.
  • On a year-over-year basis, Return on Equity [ROE] has declined for 14 consecutive quarters, with an average year-over-year change of -9.23 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 1.50 percentage points in Q4 2022, against a drop of 14.07 percentage points in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -5.98% (Q1 2026), -4.32% (Q4 2025) and -2.35% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Iqvia Holdings 45.36 Bn 36.74 Bn 1.50 Bn 21.37%
2 Medpace Holdings 18.58 Bn 16.23 Bn 223.89 Mn 101.65%
3 Charles River Laboratories International 16.56 Bn 15.80 Bn 357.87 Mn 1.40%
4 Icon 15.67 Bn 12.44 Bn 491.83 Mn 7.58%
5 Fortrea Holdings 2.06 Bn 1.35 Bn 139.50 Mn -13.01%
6 Ginkgo Bioworks Holdings 774.61 Mn 39.09 Mn 25.91 Mn -62.22%
7 Evotec SE 600.89 Mn -1.16 Bn - -
8 Champions Oncology 66.11 Mn 41.77 Mn 7.70 Mn -27.20%
9 MindWalk Holdings 48.11 Mn 11.77 Mn 1.61 Mn -182.13%
10 Natural Alternatives International 6.27 Mn -21.81 Mn 1.73 Mn -34.84%
Historic Data

Historic Data

Download Data
DateValue
Sep 26, 2026 1.40%
Jun 27, 2026 -8.16%
Mar 28, 2026 -5.98%
Dec 27, 2025 -4.32%
Sep 27, 2025 -2.35%
Jun 28, 2025 -1.98%
Mar 29, 2025 -0.70%
Dec 28, 2024 0.70%
Sep 28, 2024 11.39%
Jun 29, 2024 12.09%
Mar 30, 2024 12.44%
Dec 30, 2023 13.90%
Sep 30, 2023 14.63%
Jul 1, 2023 15.38%
Apr 1, 2023 16.45%
Dec 31, 2022 17.55%
Sep 24, 2022 16.77%
Jun 25, 2022 17.12%
Mar 26, 2022 16.69%
Dec 25, 2021 16.05%
API Access

Charles River Laboratories International Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRL&period=max&api_key=YOUR_API_KEY